Cancer Treatment Centers of America: Clincal Trials
Learn More About This Topic: Chat with Us | Email Us
Safety and Efficacy Study of Gemcitabine Combined With High Dose Intravenous Vitamin C (HDIVC) for Patients With Metastatic Adenocarcinoma of the Pancreas
Summary
This study is for patients who have been diagnosed with pancreatic cancer and have had progression of their disease after at least type one chemotherapy regimen. This study will assess the safety and tolerability of both high-dose and low-dose IV vitamin C when administered concurrently with Gemzar.
For More Information:
Please contact one of our Oncology Information Specialists at 1-800-615-3055 to learn more about this clinical trial. Oncology Information Specialists are available 24 hours a day, 7 days a week, 365 days a year.
